CXCR4-mediated signaling regulates autophagy and influences acute myeloid leukemia cell survival and drug resistance. (1st July 2018)

• Record Type: Journal Article
• Authors: Hu, Xiaojia; Mei, Shuang; Meng, Wenfang; Xue, Shihang; Jiang, Lejian; Yang, Yang; Hui, Lanlan; Chen, Ye; Guan, Min-Xin
• Is Part Of: Cancer letters. Volume 425(2018)
• Page Start: 1
• Page End: 12
• Publication Date: 2018-07-01
• Subjects: Acute myeloid leukemia -- SDF1a–CXCR4 signaling -- Chemoresistance -- Autophagy; Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Electronic journals; 616.994
• DOI: 10.1016/j.canlet.2018.03.024
• Languages: English
• ISSNs: 0304-3835

Abstract

Abstract: CXCR4 surface expression is considered an independent prognostic factor for disease relapse and survival in acute myeloid leukemia (AML) patients. Herein, we investigated targetable autophagy-related mechanisms of CXCR4 for AML therapy. Our experiments show that activation of CXCR4 signaling in AML cells increases autophagic activity and decreases cytarabine-induced apoptosis. Accordingly, combined use of autophagy inhibitors significantly increased the sensitivity of AML cells to cytarabine in vitro and in vivo . Moreover, expression of autophagy-related protein SIRT1 was correlated with SDF-1α–CXCR4 signaling, which interacts with autophagy proteins, such as ATG5 and LC3. Furthermore, in primary human AML samples, high CXCR4 expression was associated with elevated expression levels of SIRT1 and other autophagy-related proteins. Collectively, our data suggest new roles of SDF-1α–CXCR4 signaling on autophagy induction in AML cells, which further promoted their survival under stress. Targeting the SDF-1α–CXCR4–autophagy signaling may contribute to an enhanced efficacy of active treatments. Highlights: CXCR4 signaling in AML cells increases autophagic activity. High CXCR4 expression correlated with upregulated autophagy-related proteins in AML patients. Autophagy inhibition sensitized AML cells to Ara-C treatment.